Phoenix Financial’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-244,113
| Closed | -$259K | – | 400 |
|
|
2022
Q1 | $259K | Hold |
244,113
| – | – | ﹤0.01% | 343 |
|
|
2021
Q4 | $203K | Hold |
244,113
| – | – | ﹤0.01% | 358 |
|
|
2021
Q3 | $325K | Hold |
244,113
| – | – | 0.01% | 347 |
|
|
2021
Q2 | $466K | Hold |
244,113
| – | – | 0.01% | 269 |
|
|
2021
Q1 | $1.09M | Buy |
+244,113
| New | +$1.09M | 0.02% | 276 |
|
|
2020
Q4 | – | Sell |
-204,355
| Closed | -$751K | – | 415 |
|
|
2020
Q3 | $751K | Buy |
204,355
+16,019
| +9% | +$58.9K | 0.03% | 216 |
|
|
2020
Q2 | $681K | Buy |
+188,336
| New | +$681K | 0.03% | 226 |
|